Celltrion Healthcare Presents Efficacy and Safety Data From Global Phase III LIBERTY Trial, at the 18th ECCO Congress


Hitesh

Celltrion Healthcare has presented new data demonstrating the efficacy and safety of subcutaneous infliximab (SC) (CT-P13 SC) in patients with inflammatory bowel disease (IBD). The data were presented in a digital oral presentation and poster presentations at the 18th Annual General Meeting of the European Crohn’s Disease and Colitis Organization […]

Hologram Science and Haleon team up to create a personalized nutritional innovation process  


Hitesh

Hologram Science, a consumer-focused healthcare technology company dedicated to creating personalized holistic nutrition solutions, has established a strategic partnership with Haleon, a leading company. consumer health world. The collaboration focuses on innovation to address consumer health concerns in areas such as healthy aging. The partnership will also leverage Hologram Science’s […]

GE HealthCare Announces Completion of Phase I Subject Recruitment in Early Clinical Development Program for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent


Hitesh

GE HealthCare announced today at the European Congress of Radiology (ECR) in Vienna, Austria that it has completed the registration of Phase I subjects in the initial clinical development program for circumferential magnetic resonance imaging. Manganese-based large-scale, the first contrast agent of its kind (MRI). agency. Typically, MRI agents – […]

Lunit and Agfa Announce Lunit INSIGHT CXR’s Integration in Agfa’s MUSICA® Workstation; Demonstration and Presentation to be Showcased at ECR 2023


Hitesh

Lunit and Agfa Radiology Solutions today announced the integration of Lunit’s AI solution for chest radiology, Lunit INSIGHT CXR, into the MUSICA® workstation. Agfa will demonstrate the integrated product at the upcoming European Congress of Radiology (ECR) 2023, to be held in Vienna, Austria, from 1 to 5 March. Lunit […]

Agios Reports Fourth Quarter and Full Year 2022 Financial Results


Hitesh

Agios Pharmaceuticals, Inc., the leader in pioneering cellular metabolic therapies for rare diseases, today announced business highlights and financial results for the fourth quarter and fiscal year ended. ends on December 31, 2022. “Over the past year, Agios has made significant progress toward our vision of transforming the lives of […]